Table 5.
Bacterial targets used for screening of antibacterial activity from hydrolysate. BHI, Brain Heart Infusion; LB, Luria-Bertani; TSB, Tryptone Soy Broth; YE, Yeast Extract; YEG, Yeast Extract Glucose.
| Target strains | Growth Conditions | ||||
|---|---|---|---|---|---|
| Genus | Species | Collection | Type | Ecological Function | Media |
| Bacillus † | megaterium | B301 | Gram † | Non-pathogen | TSB |
| Blautia | coccoides | ATCC 29236 | Human Flora | BHI + Cysteine (0.05%) | |
| Bifidobacterium | infantis | ATCC 15697 | Human probiotic | BHI + Cysteine (0.05%) | |
| Enterococcus | faecalis | ATCC 27212 | Human pathogen | BHI | |
| Enterococcus † | faecium | L1 | Human pathogen | BHI | |
| Lactobacillus | acidophilus | ATCC 4356 | Human probiotic | TSB+YE (0.6%) | |
| Lactobacillus † | salivarius | 16 | Human probiotic | BHI + Cysteine (0.05%) | |
| Listeria | ivanovii | ATCC 19119 | Human pathogen | TSB+YE (0.6%) | |
| Listeria | monocytogenes | ATCC 15313 | Human pathogen | MRS | |
| Micrococcus † | luteus | 272 | Non-pathogen | TSB | |
| Staphylococcus | aureus | ATCC 25923 | Human pathogen | BHI | |
| Bacteroides | thetaiotaomicron | ATCC 29741 | Human pathogen | BHI + Cysteine (0.05%) | |
| Escherichia | coli | ATCC 25922 | Human pathogen | LB | |
| Pseudomonas | aeruginosa | ATCC 27853 | Human pathogen | TSB | |
| Vibrio | parahaemolyticus | ALN-0312 | Human pathogen | BHI + Sea salt (3%) | |
† Laboratoire de Microbiologie Alimentaire (LMA) strain collection (Laval University, QC, Canada).